To The Moon

Sign Up

SPOT_ON

NO PAIN NO GAINS

    • SPOT_ONSPOT_ON
      ·05-20 14:18
      Great article, would you like to share it?

      JP MORGAN MAINTAINED $420 TARGET PRICE OVERWEIGHT RATING

      @SPOT_ON：
      $Adobe(ADBE)$ JPMorgan analyst Mark R. Murphy maintained an Overweight rating on Adobe with a $420 price forecast on Wednesday, saying the firm left the Summit “incrementally more positive” on Adobe’s positioning in the agentic AI era. He pointed to Adobe’s strategy of acting as an “orchestration, intelligence, and governance layer” across AI platforms, supported by products like CX Enterprise and broad partnerships with major AI ecosystems. Murphy also pointed to NVIDIA CEO Jensen Huang‘s endorsement as a key validation. Huang said, “For 99.9% of creators in the world, this [agentic system] is going to elevate your art,” adding that “NVIDIA marketing is built on Adobe… Adobe is going to be the marketing
      JP MORGAN MAINTAINED $420 TARGET PRICE OVERWEIGHT RATING
      1Comment
      Report
    • SPOT_ONSPOT_ON
      ·05-20 07:34
      Great article, would you like to share it?

      JP MORGAN MAINTAINED $420 TARGET PRICE OVERWEIGHT RATING

      @SPOT_ON：
      $Adobe(ADBE)$ JPMorgan analyst Mark R. Murphy maintained an Overweight rating on Adobe with a $420 price forecast on Wednesday, saying the firm left the Summit “incrementally more positive” on Adobe’s positioning in the agentic AI era. He pointed to Adobe’s strategy of acting as an “orchestration, intelligence, and governance layer” across AI platforms, supported by products like CX Enterprise and broad partnerships with major AI ecosystems. Murphy also pointed to NVIDIA CEO Jensen Huang‘s endorsement as a key validation. Huang said, “For 99.9% of creators in the world, this [agentic system] is going to elevate your art,” adding that “NVIDIA marketing is built on Adobe… Adobe is going to be the marketing
      JP MORGAN MAINTAINED $420 TARGET PRICE OVERWEIGHT RATING
      3Comment
      Report
    • SPOT_ONSPOT_ON
      ·05-19 21:53
      [Call] [Call] [Call] [Call] [Call] [USD]

      JP MORGAN MAINTAINED $420 TARGET PRICE OVERWEIGHT RATING

      @SPOT_ON：
      $Adobe(ADBE)$ JPMorgan analyst Mark R. Murphy maintained an Overweight rating on Adobe with a $420 price forecast on Wednesday, saying the firm left the Summit “incrementally more positive” on Adobe’s positioning in the agentic AI era. He pointed to Adobe’s strategy of acting as an “orchestration, intelligence, and governance layer” across AI platforms, supported by products like CX Enterprise and broad partnerships with major AI ecosystems. Murphy also pointed to NVIDIA CEO Jensen Huang‘s endorsement as a key validation. Huang said, “For 99.9% of creators in the world, this [agentic system] is going to elevate your art,” adding that “NVIDIA marketing is built on Adobe… Adobe is going to be the marketing
      JP MORGAN MAINTAINED $420 TARGET PRICE OVERWEIGHT RATING
      14Comment
      Report
    • SPOT_ONSPOT_ON
      ·05-19 21:52
      Singapore’s Home Team Science and Technology Agency (HTX) is working with Adobe to test tools that can verify whether digital images and documents have been altered, as deepfakes and synthetic media become harder for public agencies to assess. HTX and Adobe signed a two-year memorandum of understanding (MOU) focused on content provenance, which records the origin, history and edits made to digital files. The work is aimed at strengthening public safety and trust in images, documents and other digital material used by public agencies. The agency plans to create a proof of concept based on the Content Authenticity Initiative (CAI) and the Coalition for Content Provenance and Authenticity (C2PA) standards. It will align with Adobe’s Content Credentials framework, which is designed to carry ta

      JP MORGAN MAINTAINED $420 TARGET PRICE OVERWEIGHT RATING

      @SPOT_ON：
      $Adobe(ADBE)$ JPMorgan analyst Mark R. Murphy maintained an Overweight rating on Adobe with a $420 price forecast on Wednesday, saying the firm left the Summit “incrementally more positive” on Adobe’s positioning in the agentic AI era. He pointed to Adobe’s strategy of acting as an “orchestration, intelligence, and governance layer” across AI platforms, supported by products like CX Enterprise and broad partnerships with major AI ecosystems. Murphy also pointed to NVIDIA CEO Jensen Huang‘s endorsement as a key validation. Huang said, “For 99.9% of creators in the world, this [agentic system] is going to elevate your art,” adding that “NVIDIA marketing is built on Adobe… Adobe is going to be the marketing
      JP MORGAN MAINTAINED $420 TARGET PRICE OVERWEIGHT RATING
      83Comment
      Report
    • SPOT_ONSPOT_ON
      ·05-19 21:08

      JP MORGAN MAINTAINED $420 TARGET PRICE OVERWEIGHT RATING

      $Adobe(ADBE)$    JPMorgan analyst Mark R. Murphy maintained an Overweight rating on Adobe with a $420 price forecast on Wednesday, saying the firm left the Summit “incrementally more positive” on Adobe’s positioning in the agentic AI era. He pointed to Adobe’s strategy of acting as an “orchestration, intelligence, and governance layer” across AI platforms, supported by products like CX Enterprise and broad partnerships with major AI ecosystems. Murphy also pointed to NVIDIA CEO Jensen Huang‘s endorsement as a key validation. Huang said, “For 99.9% of creators in the world, this [agentic system] is going to elevate your art,” adding that “NVIDIA marketing is built on Adobe… Adobe is going to be the marketing
      5437
      Report
      JP MORGAN MAINTAINED $420 TARGET PRICE OVERWEIGHT RATING
    • SPOT_ONSPOT_ON
      ·05-04
      Great article, would you like to share it?

      GOLDMAN SACHS RAISED UNITEDHEALTH GROUP TARGET TO $435 !!

      @SPOT_ON：
      $UnitedHealth(UNH)$ Investment banker Goldman Sachs recently raised its price target for UnitedHealth Group Incorporated (UNH) shares from $400 to $435, citing the company’s increased full-year guidance, announced in its latest quarterly results release, as evidence of UnitedHealth’s long-term earnings growth potential (as cited in Investing.com). Goldman Sachs (NYSE:GS | GS Price Prediction) added UnitedHealth Group (NYSE:UNH) stock to its U.S. Conviction List, reiterating a Buy rating with a $435 price target. The firm argues UnitedHealth is nearing the bottom of its underwriting cycle in Medicare Advantage (MA), which represents 40% of its business. The Conviction List is reserved for Goldman’s highest-convi
      GOLDMAN SACHS RAISED UNITEDHEALTH GROUP TARGET TO $435 !!
      462Comment
      Report
    • SPOT_ONSPOT_ON
      ·05-04
      Great article, would you like to share it?

      Nvidia's JENSEN endorsed ADOBE and JP Morgan upgrade ADOBE’S target to $420

      @SPOT_ON：
      JPMorgan analyst Mark R. Murphy maintained an Overweight rating on Adobe with a $420 price forecast on Wednesday, saying the firm left the Summit “incrementally more positive” on Adobe’s positioning in the agentic AI era. He pointed to Adobe’s strategy of acting as an “orchestration, intelligence, and governance layer” across AI platforms, supported by products like CX Enterprise and broad partnerships with major AI ecosystems. Murphy also pointed to NVIDIA CEO Jensen Huang‘s endorsement as a key validation. Huang said, “For 99.9% of creators in the world, this [agentic system] is going to elevate your art,” adding that “NVIDIA marketing is built on Adobe… Adobe is going to be the marketing manufacturing system.” Murphy viewed this as reinforcing Adobe’s relevance in an AI-driven ecosystem
      Nvidia's JENSEN endorsed ADOBE and JP Morgan upgrade ADOBE’S target to $420
      397Comment
      Report
    • SPOT_ONSPOT_ON
      ·05-04
      Great article, would you like to share it?

      GOLDMAN SACHS RAISED UNITEDHEALTH GROUP TARGET TO $435 !!

      @SPOT_ON：
      $UnitedHealth(UNH)$ Investment banker Goldman Sachs recently raised its price target for UnitedHealth Group Incorporated (UNH) shares from $400 to $435, citing the company’s increased full-year guidance, announced in its latest quarterly results release, as evidence of UnitedHealth’s long-term earnings growth potential (as cited in Investing.com). Goldman Sachs (NYSE:GS | GS Price Prediction) added UnitedHealth Group (NYSE:UNH) stock to its U.S. Conviction List, reiterating a Buy rating with a $435 price target. The firm argues UnitedHealth is nearing the bottom of its underwriting cycle in Medicare Advantage (MA), which represents 40% of its business. The Conviction List is reserved for Goldman’s highest-convi
      GOLDMAN SACHS RAISED UNITEDHEALTH GROUP TARGET TO $435 !!
      311Comment
      Report
    • SPOT_ONSPOT_ON
      ·05-04
      $BABA-W(09988)$   $MEITUAN-W(03690)$   $CATL(03750)$   $Sea Ltd(SE)$   LOAD UP UNITED HEALTH CHEAP 

      GOLDMAN SACHS RAISED UNITEDHEALTH GROUP TARGET TO $435 !!

      @SPOT_ON：
      $UnitedHealth(UNH)$ Investment banker Goldman Sachs recently raised its price target for UnitedHealth Group Incorporated (UNH) shares from $400 to $435, citing the company’s increased full-year guidance, announced in its latest quarterly results release, as evidence of UnitedHealth’s long-term earnings growth potential (as cited in Investing.com). Goldman Sachs (NYSE:GS | GS Price Prediction) added UnitedHealth Group (NYSE:UNH) stock to its U.S. Conviction List, reiterating a Buy rating with a $435 price target. The firm argues UnitedHealth is nearing the bottom of its underwriting cycle in Medicare Advantage (MA), which represents 40% of its business. The Conviction List is reserved for Goldman’s highest-convi
      GOLDMAN SACHS RAISED UNITEDHEALTH GROUP TARGET TO $435 !!
      511Comment
      Report
    • SPOT_ONSPOT_ON
      ·05-04
      Great article, would you like to share it?

      GOLDMAN SACHS RAISED UNITEDHEALTH GROUP TARGET TO $435 !!

      @SPOT_ON：
      $UnitedHealth(UNH)$ Investment banker Goldman Sachs recently raised its price target for UnitedHealth Group Incorporated (UNH) shares from $400 to $435, citing the company’s increased full-year guidance, announced in its latest quarterly results release, as evidence of UnitedHealth’s long-term earnings growth potential (as cited in Investing.com). Goldman Sachs (NYSE:GS | GS Price Prediction) added UnitedHealth Group (NYSE:UNH) stock to its U.S. Conviction List, reiterating a Buy rating with a $435 price target. The firm argues UnitedHealth is nearing the bottom of its underwriting cycle in Medicare Advantage (MA), which represents 40% of its business. The Conviction List is reserved for Goldman’s highest-convi
      GOLDMAN SACHS RAISED UNITEDHEALTH GROUP TARGET TO $435 !!
      555Comment
      Report
       
       
       
       

      Most Discussed